Cite
APA Citation
Sadushi-Kolici, R., Jansa, P., Kopec, G., Torbicki, A., Skoro-Sajer, N., Campean, I., Halank, M., Simkova, I., Karlocai, K., Steringer-Mascherbauer, R., Samarzija, M., Salobir, B., Klepetko, W., Lindner, J., & Lang, I. M. (2019). subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. Lancet, 7(3), 239–248. http://access.bl.uk/ark:/81055/vdc_100077975413.0x000005